Linda S Grais - Net Worth and Insider Trading

Linda S Grais Net Worth

The estimated net worth of Linda S Grais is at least $164,890 dollars as of 2025-04-28. Linda S Grais is the President and CEO of Ocera Therapeutics Inc and owns about 70,000 shares of Ocera Therapeutics Inc (OCRX) stock worth over $125,300. Linda S Grais is the Director of Corvus Pharmaceuticals Inc and owns about 10,000 shares of Corvus Pharmaceuticals Inc (CRVS) stock worth over $36,300. Linda S Grais is also the Director of ARCA biopharma Inc and owns about 129 shares of ARCA biopharma Inc (ABIO) stock worth over $3,290. Details can be seen in Linda S Grais's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Linda S Grais has not made any transactions after 2023-05-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Linda S Grais

Linda S Grais Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Linda S Grais owns 8 companies in total, including Deerfield Healthcare Technology Acquisitions Corp (DFHTU) , Zosano Pharma Corp (ZSANQ) , and Corvus Pharmaceuticals Inc (CRVS) among others .

Click here to see the complete history of Linda S Grais’s form 4 insider trades.

Insider Ownership Summary of Linda S Grais

Ticker	Company	Transaction Date	Type of Owner
DFHTU	Deerfield Healthcare Technology Acquisitions Corp	2020-07-16	director
ZSANQ	Zosano Pharma Corp	2020-06-25	director
CRVS	Corvus Pharmaceuticals Inc	2023-05-15	director
		2020-05-18	director
		2016-02-11	director
		2017-12-11	director & President and CEO
		2007-11-20	10 percent owner
		2020-07-16	director

Linda S Grais Latest Holdings Summary

Linda S Grais currently owns a total of 3 stocks. Among these stocks, Linda S Grais owns 70,000 shares of Ocera Therapeutics Inc (OCRX) as of December 7, 2016, with a value of $125,300 and a weighting of 75.99%. Linda S Grais owns 10,000 shares of Corvus Pharmaceuticals Inc (CRVS) as of May 15, 2023, with a value of $36,300 and a weighting of 22.01%. Linda S Grais also owns 129 shares of ARCA biopharma Inc (ABIO) as of March 29, 2010, with a value of $3,290 and a weighting of 1.99%.

Latest Holdings of Linda S Grais

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
OCRX	Ocera Therapeutics Inc	2016-12-07	70,000	1.79	125,300
CRVS	Corvus Pharmaceuticals Inc	2023-05-15	10,000	3.63	36,300
ABIO	ARCA biopharma Inc	2010-03-29	129	25.50	3,290

Holding Weightings of Linda S Grais

Linda S Grais Form 4 Trading Tracker

According to the SEC Form 4 filings, Linda S Grais has made a total of 0 transactions in Ocera Therapeutics Inc (OCRX) over the past 5 years. The most-recent trade in Ocera Therapeutics Inc is the acquisition of 7,000 shares on December 7, 2016, which cost Linda S Grais around $14,980.

According to the SEC Form 4 filings, Linda S Grais has made a total of 1 transactions in Corvus Pharmaceuticals Inc (CRVS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Corvus Pharmaceuticals Inc is the acquisition of 10,000 shares on May 15, 2023, which cost Linda S Grais around $24,500.

According to the SEC Form 4 filings, Linda S Grais has made a total of 0 transactions in ARCA biopharma Inc (ABIO) over the past 5 years. The most-recent trade in ARCA biopharma Inc is the sale of 23 shares on March 29, 2010, which brought Linda S Grais around $2 Million.

Insider Trading History of Linda S Grais

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Linda S Grais Trading Performance

GuruFocus tracks the stock performance after each of Linda S Grais's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Linda S Grais is -5.25%. GuruFocus also compares Linda S Grais's trading performance to market benchmark return within the same time period. The performance of stocks bought by Linda S Grais within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Linda S Grais's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Linda S Grais

Average Return

Average return per transaction

Outperforming Transactions

1 out of 6 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	9.55
Relative Return to S&P 500(%)	7.27

Linda S Grais Ownership Network

Ownership Network List of Linda S Grais

No Data

Ownership Network Relation of Linda S Grais

Linda S Grais Owned Company Details

What does Deerfield Healthcare Technology Acquisitions Corp do?

Who are the key executives at Deerfield Healthcare Technology Acquisitions Corp?

Linda S Grais is the director of Deerfield Healthcare Technology Acquisitions Corp. Other key executives at Deerfield Healthcare Technology Acquisitions Corp include director & 10 percent owner & other: Director by Deputization Deerfield Management Company, L.p. (series C) , director & 10 percent owner & other: Director by Deputization Deerfield Mgmt L.p. , and director & 10 percent owner & other: Director by Deputization Deerfield Partners, L.p. .

Deerfield Healthcare Technology Acquisitions Corp (DFHTU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Deerfield Healthcare Technology Acquisitions Corp (DFHTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Deerfield Healthcare Technology Acquisitions Corp Insider Transactions

No Available Data

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

Linda S Grais is the director of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include director & Chief Executive Officer Steven Lo , Chief Financial Officer Christine Matthews , and VP & Clinical Dev & Med Affairs Donald J Kellerman .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zosano Pharma Corp Insider Transactions

No Available Data

What does Corvus Pharmaceuticals Inc do?

Who are the key executives at Corvus Pharmaceuticals Inc?

Linda S Grais is the director of Corvus Pharmaceuticals Inc. Other key executives at Corvus Pharmaceuticals Inc include director & President and CEO Miller Richard A Md , See Remarks William Benton Jones , and Chief Financial Officer Leiv Lea .

Corvus Pharmaceuticals Inc (CRVS) Insider Trades Summary

Over the past 18 months, Linda S Grais made no insider transaction in Corvus Pharmaceuticals Inc (CRVS). Other recent insider transactions involving Corvus Pharmaceuticals Inc (CRVS) include a net purchase of 577,634 shares made by Miller Richard A Md , and a net purchase of 20,000 shares made by William Benton Jones .

In summary, during the past 3 months, insiders sold 0 shares of Corvus Pharmaceuticals Inc (CRVS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corvus Pharmaceuticals Inc (CRVS) were sold and 597,634 shares were bought by its insiders, resulting in a net purchase of 597,634 shares.

Corvus Pharmaceuticals Inc (CRVS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Corvus Pharmaceuticals Inc Insider Transactions

No Available Data

What does PRA Health Sciences Inc do?

Who are the key executives at PRA Health Sciences Inc?

Linda S Grais is the director of PRA Health Sciences Inc. Other key executives at PRA Health Sciences Inc include EVP & CFO Michael J. Bonello , director & President & CEO Shannon Colin , and EVP & CAO & General Counsel Christopher L Gaenzle .

PRA Health Sciences Inc (PRAH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PRA Health Sciences Inc (PRAH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PRA Health Sciences Inc (PRAH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PRA Health Sciences Inc (PRAH)'s detailed insider trading history can be found in Insider Trading Tracker table.

PRA Health Sciences Inc Insider Transactions

No Available Data

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Linda S Grais is the director of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

Over the past 18 months, Linda S Grais made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

What does Ocera Therapeutics Inc do?

Who are the key executives at Ocera Therapeutics Inc?

Linda S Grais is the director & President and CEO of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .

Ocera Therapeutics Inc (OCRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocera Therapeutics Inc Insider Transactions

No Available Data

What does Reshape Lifesciences Inc do?

Who are the key executives at Reshape Lifesciences Inc?

Linda S Grais is the 10 percent owner of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .

Reshape Lifesciences Inc (RSLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reshape Lifesciences Inc Insider Transactions

No Available Data

What does CareMax Inc do?

Who are the key executives at CareMax Inc?

Linda S Grais is the director of CareMax Inc. Other key executives at CareMax Inc include director & 10 percent owner De La Torre Ralph , EVP and COO Solo Alberto De , and director & President and CEO De Solo Carlos A. .

CareMax Inc (CMAXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CareMax Inc (CMAXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CareMax Inc (CMAXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CareMax Inc (CMAXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

CareMax Inc Insider Transactions

No Available Data

Linda S Grais Mailing Address

Above is the net worth, insider trading, and ownership report for Linda S Grais. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Linda S Grais's mailing address is: Atherton Ca 94027.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.